-
-
Enroll in the Living With Type 2 Diabetes Program
Recently diagnosed? Let us guide you during your first year.
-
-
-
Volunteer Center
There are life-changing opportunities in your community to inspire healthy living, advocate for change, and help with events.
-
-
About Us
New to Type 2?
Enroll in the Living With Type 2 Diabetes program and let us guide you through your first year with type 2 diabetes.
Outstanding Physician Clinician in Diabetes Award
Jerry P. Palmer, MD
Jerry P. Palmer, MD, from Seattle, Washington, received the American Diabetes Association’s prestigious 2011 Outstanding Physician Clinician in Diabetes Award. The award was presented at the Association’s 71st Scientific Sessions in San Diego, California.
The Outstanding Physician Clinician in Diabetes Award is presented to an individual who has made outstanding efforts in diabetes care and is recognized as a highly regarded clinician and educator with more than 10 years of distinguished service.
Currently a professor in the Department of Medicine and director of the Diabetes Endocrinology Research Center, University of Washington, and chief of the Division of Endocrinology, Metabolism, and Nutrition, Veterans Affairs Puget Sound Health Care System, Seattle, Palmer has a distinguished career as clinician, educator, mentor, and scientist.
Known internationally for his discovery of insulin autoantibodies, Palmer also is held in high regard locally as a clinician, in part because he implements research findings to help patients. Palmer was a principal investigator of the Seattle Diabetes Control and Complications Trial (DCCT) site. Realizing the importance of the multidisciplinary approach, he created the Diabetes Care Center within the University of Washington. This clinic has developed an international reputation as a premier academic diabetes center. Palmer is also a clinician and teacher in the Veterans Affairs Endocrine Clinic, a popular clinic for students, residents and fellows.
Palmer has served on the board of the American Diabetes Association’s Washington affiliate (1975-1983), and on the national board (1994-1997). He was on the National Institutes of Health steering committee for the Diabetes Prevention Trial–Type 1 (DPT-1) and now for Type 1 Diabetes TrialNet, and is on the international executive committee for the TRIGR study.
